| HGNC Family | Ankyrin repeat domain containing (ANKRD), Parkinson disease associated genes (PARK), Patatin-like phospholipase domain containing (PNPLA), Phospholipases |
| Name | phospholipase A2, group VI (cytosolic, calcium-independent) |
| Description | The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date. [provided by RefSeq, Dec 2010] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPLA2G6 encodes the group VIA calcium‐independent phospholipase A₂β enzyme, which catalyzes the hydrolysis of membrane glycerophospholipids at the sn‑2 position to release free fatty acids and lysophospholipids. Such lipid mediators are essential for membrane remodeling, phospholipid turnover, and the generation of bioactive species that modulate energy storage and signaling. For example, studies in adipocytes have shown that PLA2G6 family members not only display triacylglycerol lipase and acylglycerol transacylase activities but also contribute to phospholipid remodeling in a manner that can regulate cellular lipid composition and even influence the activation of thermosensitive channels in tissues such as the prostate."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDysfunction of PLA2G6 has been strongly linked to a spectrum of neurodegenerative disorders. Mutations in its gene are the cause of infantile neuroaxonal dystrophy (INAD), neurodegeneration with brain iron accumulation (NBIA), and early‐onset dystonia‐parkinsonism, among others. The enzyme’s impaired phospholipid hydrolysis disrupts membrane homeostasis, promotes mitochondrial abnormalities and lipid peroxidation, and leads to the aberrant accumulation of toxic lipid species—all of which contribute to neuronal degeneration, tau and α‑synuclein pathology, and parkinsonian features. Genetic screens and pathological examinations across diverse patient cohorts have underscored its central role in these disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in membrane remodeling and neuronal health, PLA2G6 influences diverse cellular processes such as cell signaling, oxidative stress responses, and inflammation. Its activity contributes to the liberation of lipid second messengers that can modulate the cell cycle, regulate apoptotic processes, and even control innate immune cell migration and superoxide production. Detailed biochemical and structural studies have revealed that the enzyme’s activity is finely tuned by protein interactions and intracellular signaling molecules, while its dysregulation may promote ferroptotic cell death and affect tumor biology as well as pancreatic β‑cell function. Together, these findings position PLA2G6 as a central regulator of lipid homeostasis and signal transduction with far‐reaching impacts on cellular physiology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "29", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Christopher M Jenkins, David J Mancuso, Wei Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M407841200"}], "href": "https://doi.org/10.1074/jbc.M407841200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15364929"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15364929"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sun Jun Kim, Debra Gershov, Xiaojing Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20020542"}], "href": "https://doi.org/10.1084/jem.20020542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12208880"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12208880"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Fabien Vanden Abeele, Alexander Zholos, Gabriel Bidaux, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ca2+-independent phospholipase A2-dependent gating of TRPM8 by lysophospholipids."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M605779200"}], "href": "https://doi.org/10.1074/jbc.M605779200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17082190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17082190"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Christina C Leslie "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of arachidonic acid availability for eicosanoid production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Cell Biol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1139/o03-080"}], "href": "https://doi.org/10.1139/o03-080"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15052324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15052324"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Patricia K Tithof, Mary P Roberts, Wei Guan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct phospholipase A2 enzymes regulate prostaglandin E2 and F2alpha production by bovine endometrial epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biol Endocrinol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1477-7827-5-16"}], "href": "https://doi.org/10.1186/1477-7827-5-16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17459165"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17459165"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Mario Falchi, Veronique Bataille, Nicholas K Hayward, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.410"}], "href": "https://doi.org/10.1038/ng.410"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19578365"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19578365"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Julia A Newton-Bishop, Yu-Mei Chang, Mark M Iles, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-10-0233"}], "href": "https://doi.org/10.1158/1055-9965.EPI-10-0233"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20647408"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20647408"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Neil V Morgan, Shawn K Westaway, Jenny E V Morton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng1826"}], "href": "https://doi.org/10.1038/ng1826"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16783378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16783378"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Coro Paisan-Ruiz, Kailash P Bhatia, Abi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of PLA2G6 as a locus for dystonia-parkinsonism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.21415"}], "href": "https://doi.org/10.1002/ana.21415"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18570303"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18570303"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "A Gregory, S K Westaway, I E Holm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neurodegeneration associated with genetic defects in phospholipase A(2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000327094.67726.28"}], "href": "https://doi.org/10.1212/01.wnl.0000327094.67726.28"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18799783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18799783"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Delin Chen, Bo Chu, Xin Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-23902-6"}], "href": "https://doi.org/10.1038/s41467-021-23902-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34131139"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34131139"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Coro Paisán-Ruiz, Rocio Guevara, Monica Federoff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mov Disord (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mds.23221"}], "href": "https://doi.org/10.1002/mds.23221"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20669327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20669327"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Coro Paisán-Ruiz, Abi Li, Susanne A Schneider, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2010.05.009"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2010.05.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20619503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20619503"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Susan J Hayflick, Manju A Kurian, Penelope Hogarth "}, {"type": "b", "children": [{"type": "t", "text": "Neurodegeneration with brain iron accumulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Handb Clin Neurol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/B978-0-444-63233-3.00019-1"}], "href": "https://doi.org/10.1016/B978-0-444-63233-3.00019-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29325618"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29325618"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Kerri J Kinghorn, Jorge Iván Castillo-Quan, Fernando Bartolome, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awv132"}], "href": "https://doi.org/10.1093/brain/awv132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26001724"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26001724"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Guang Lin, Pei-Tseng Lee, Kuchuan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to α-Synuclein Gain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2018.05.019"}], "href": "https://doi.org/10.1016/j.cmet.2018.05.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29909971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29909971"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "H Yoshino, H Tomiyama, N Tachibana, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e3181f73649"}], "href": "https://doi.org/10.1212/WNL.0b013e3181f73649"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20938027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20938027"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Laura A Engel, Zheng Jing, Daniel E O'Brien, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0012897"}], "href": "https://doi.org/10.1371/journal.pone.0012897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20886109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20886109"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "C-h Shi, B-s Tang, L Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e318221acd3"}], "href": "https://doi.org/10.1212/WNL.0b013e318221acd3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21700586"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21700586"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Qingde Zhou, Allen Yen, Grzegorz Rymarczyk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms10332"}], "href": "https://doi.org/10.1038/ncomms10332"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26755131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26755131"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "F Sina, S Shojaee, E Elahi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1468-1331.2008.02356.x"}], "href": "https://doi.org/10.1111/j.1468-1331.2008.02356.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19087156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19087156"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "M A Illingworth, E Meyer, W K Chong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2014.03.008"}], "href": "https://doi.org/10.1016/j.ymgme.2014.03.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24745848"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24745848"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Peter Csutora, Vladislav Zarayskiy, Krisztina Peter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation mechanism for CRAC current and store-operated Ca2+ entry: calcium influx factor and Ca2+-independent phospholipase A2beta-mediated pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M606504200"}], "href": "https://doi.org/10.1074/jbc.M606504200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17003039"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17003039"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "B Ozes, N Karagoz, R Schüle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G6 mutations associated with a continuous clinical spectrum from neuroaxonal dystrophy to hereditary spastic paraplegia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cge.13008"}], "href": "https://doi.org/10.1111/cge.13008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28295203"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28295203"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Y Wu, Y Jiang, Z Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical study and PLA2G6 mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1468-1331.2008.02397.x"}], "href": "https://doi.org/10.1111/j.1468-1331.2008.02397.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19138334"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19138334"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Shunzhong Bao, Chun Jin, Sheng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Beta-cell calcium-independent group VIA phospholipase A(2) (iPLA(2)beta): tracking iPLA(2)beta movements in response to stimulation with insulin secretagogues in INS-1 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/diabetes.53.2007.s186"}], "href": "https://doi.org/10.2337/diabetes.53.2007.s186"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14749286"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14749286"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Manar Aoun, Valeria Tiranti "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondria: A crossroads for lipid metabolism defect in neurodegeneration with brain iron accumulation diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2015.01.018"}], "href": "https://doi.org/10.1016/j.biocel.2015.01.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25668476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25668476"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Annu Aggarwal, Susanne A Schneider, Henry Houlden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mov Disord (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mds.23095"}], "href": "https://doi.org/10.1002/mds.23095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20629144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20629144"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Ofer Beharier, Vladimir A Tyurin, Julie P Goff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G6 guards placental trophoblasts against ferroptotic injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2009201117"}], "href": "https://doi.org/10.1073/pnas.2009201117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33087576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33087576"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Rebeca Pérez, Roberto Melero, María A Balboa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of group VIA calcium-independent phospholipase A2 in arachidonic acid release, phospholipid fatty acid incorporation, and apoptosis in U937 cells responding to hydrogen peroxide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M402562200"}], "href": "https://doi.org/10.1074/jbc.M402562200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15252038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15252038"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Shelley B Hooks, Brian S Cummings "}, {"type": "b", "children": [{"type": "t", "text": "Role of Ca2+-independent phospholipase A2 in cell growth and signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2008.07.044"}], "href": "https://doi.org/10.1016/j.bcp.2008.07.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18775417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18775417"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Ravi S Mishra, Kevin A Carnevale, Martha K Cathcart "}, {"type": "b", "children": [{"type": "t", "text": "iPLA2beta: front and center in human monocyte chemotaxis to MCP-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20071243"}], "href": "https://doi.org/10.1084/jem.20071243"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18208975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18208975"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Varnavas D Mouchlis, Yuan Chen, J Andrew McCammon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Membrane Allostery and Unique Hydrophobic Sites Promote Enzyme Substrate Specificity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Chem Soc (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/jacs.7b12045"}], "href": "https://doi.org/10.1021/jacs.7b12045"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29342349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29342349"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Srinivas Ayilavarapu, Alpdogan Kantarci, Gabrielle Fredman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0901219"}], "href": "https://doi.org/10.4049/jimmunol.0901219"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20053941"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20053941"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Yuan-Hao Hsu, John E Burke, Sheng Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Localizing the membrane binding region of Group VIA Ca2+-independent phospholipase A2 using peptide amide hydrogen/deuterium exchange mass spectrometry."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.021857"}], "href": "https://doi.org/10.1074/jbc.M109.021857"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19556238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19556238"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Chin-Song Lu, Szu-Chia Lai, Ruey-Meei Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.32012"}], "href": "https://doi.org/10.1002/ajmg.b.32012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22213678"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22213678"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "M H Law, R G H Cotton, G E Berger "}, {"type": "b", "children": [{"type": "t", "text": "The role of phospholipases A2 in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4001819"}], "href": "https://doi.org/10.1038/sj.mp.4001819"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16585943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16585943"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Konstantin R Malley, Olga Koroleva, Ian Miller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The structure of iPLA"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "β reveals dimeric active sites and suggests mechanisms of regulation and localization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-03193-0"}], "href": "https://doi.org/10.1038/s41467-018-03193-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29472584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29472584"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Alex D Manguikian, Suzanne E Barbour "}, {"type": "b", "children": [{"type": "t", "text": "Cell cycle dependence of group VIA calcium-independent phospholipase A2 activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M410659200"}], "href": "https://doi.org/10.1074/jbc.M410659200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15385540"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15385540"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "John Turk, Sasanka Ramanadham "}, {"type": "b", "children": [{"type": "t", "text": "The expression and function of a group VIA calcium-independent phospholipase A2 (iPLA2beta) in beta-cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Can J Physiol Pharmacol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1139/y04-064"}], "href": "https://doi.org/10.1139/y04-064"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15573142"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15573142"}]}]}]}
|
| Synonyms | GVI, INAD1, NBIA2, NBIA2B, NBIA2A, CAI-PLA2, IPLA2BETA, PARK14, PNPLA9, IPLA2-VIA, IPLA2 |
| Proteins | PLPL9_HUMAN |
| NCBI Gene ID | 8398 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PLA2G6 has 10,156 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 131 datasets.
Click the + buttons to view associations for PLA2G6 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PLA2G6 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PLA2G6 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PLA2G6 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PLA2G6 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PLA2G6 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PLA2G6 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PLA2G6 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PLA2G6 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PLA2G6 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PLA2G6 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PLA2G6 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PLA2G6 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PLA2G6 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PLA2G6 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PLA2G6 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PLA2G6 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PLA2G6 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with PLA2G6 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with PLA2G6 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PLA2G6 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PLA2G6 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PLA2G6 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing PLA2G6 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PLA2G6 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PLA2G6 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PLA2G6 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PLA2G6 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PLA2G6 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PLA2G6 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PLA2G6 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PLA2G6 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PLA2G6 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving PLA2G6 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving PLA2G6 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with PLA2G6 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PLA2G6 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PLA2G6 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PLA2G6 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PLA2G6 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PLA2G6 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PLA2G6 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PLA2G6 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PLA2G6 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PLA2G6 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PLA2G6 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PLA2G6 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PLA2G6 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PLA2G6 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PLA2G6 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PLA2G6 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PLA2G6 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PLA2G6 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PLA2G6 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PLA2G6 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PLA2G6 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PLA2G6 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PLA2G6 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PLA2G6 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PLA2G6 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PLA2G6 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing PLA2G6 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PLA2G6 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PLA2G6 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PLA2G6 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PLA2G6 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PLA2G6 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PLA2G6 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PLA2G6 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with PLA2G6 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PLA2G6 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PLA2G6 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PLA2G6 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PLA2G6 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PLA2G6 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PLA2G6 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PLA2G6 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PLA2G6 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PLA2G6 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with PLA2G6 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PLA2G6 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PLA2G6 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| HumanCyc Pathways | pathways involving PLA2G6 protein from the HumanCyc Pathways dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PLA2G6 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PLA2G6 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PLA2G6 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PLA2G6 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PLA2G6 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving PLA2G6 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving PLA2G6 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PLA2G6 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PLA2G6 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PLA2G6 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PLA2G6 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PLA2G6 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PLA2G6 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing PLA2G6 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PLA2G6 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PLA2G6 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PLA2G6 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PLA2G6 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PLA2G6 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PLA2G6 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for PLA2G6 protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PLA2G6 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing PLA2G6 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with PLA2G6 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PLA2G6 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PLA2G6 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PLA2G6 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PLA2G6 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PLA2G6 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with PLA2G6 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| Reactome Pathways 2014 | pathways involving PLA2G6 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PLA2G6 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PLA2G6 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PLA2G6 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PLA2G6 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PLA2G6 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PLA2G6 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PLA2G6 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PLA2G6 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PLA2G6 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PLA2G6 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PLA2G6 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PLA2G6 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PLA2G6 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PLA2G6 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PLA2G6 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PLA2G6 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PLA2G6 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PLA2G6 protein from the WikiPathways Pathways 2024 dataset. | |